Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

GnRH Agonist · Endocrine

Histrelin (Supprelin LA / Vantas)

GnRH agonist implant for central precocious puberty and prostate cancer.

FDA-Approved

Plain-Language Label Highlights

Brand names: Supprelin LA, Vantas

What it's approved for

Central precocious puberty (Supprelin LA) and advanced prostate cancer (Vantas).

A small under-the-skin implant replaced once a year that quietly lowers sex hormones the whole time.

Common side effects
  • Implant-site reactions (redness, soreness, bruising)
  • Hot flashes
  • Fatigue
  • Headache
Serious risks to know
  • Implant breakage at removal
  • Cardiovascular and metabolic effects with long-term use
  • Bone density loss
Who should avoid or use with extra caution
  • Pregnancy
  • Known hypersensitivity to GnRH analogs

Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.

Mechanism of Action

Synthetic nonapeptide GnRH agonist delivered via a subcutaneous hydrogel implant providing continuous release for 12 months, desensitizing the pituitary and suppressing sex steroids.

Research Areas

Central precocious puberty (Supprelin LA)
Advanced prostate cancer (Vantas)

Common Research Protocols

Annual implant

50 mg SC implant in inner upper arm; replaced every 12 months.

Protocols summarized for educational reference from published research. Not dosing guidance.

Cited Research

[1]JCEM·2007

Histrelin implant in CPP

Sustained suppression of pubertal progression with single annual implant.

Important Considerations

  • FDA-approved.
  • Implant site reactions and rare implant breakage at removal.

Explore more peptides

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries Histrelin (Supprelin LA / Vantas)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.